Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedSep 26, 2025
DataAggregated Company Financials
Companies9
  • 7D-5.9%
  • 3M-3.7%
  • 1Y1.3%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 4.2%, driven by pullbacks from every company within the industry. In the past year, the industry has gained 5.3%. Earnings are forecast to grow by 29% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Sep 2025SEK 34.0bSEK 14.7bSEK 61.3m56.4x555x2.3x
Sun, 24 Aug 2025SEK 35.4bSEK 14.7bSEK 59.9m58.8x591.4x2.4x
Tue, 22 Jul 2025SEK 46.1bSEK 16.7bSEK 444.3m62.1x103.8x2.8x
Thu, 19 Jun 2025SEK 46.5bSEK 16.6bSEK 405.8m71.1x114.7x2.8x
Sat, 17 May 2025SEK 46.4bSEK 16.6bSEK 415.3m45x111.7x2.8x
Mon, 14 Apr 2025SEK 34.9bSEK 16.6bSEK 609.4m36.9x57.3x2.1x
Wed, 12 Mar 2025SEK 36.4bSEK 16.6bSEK 614.9m39.2x59.2x2.2x
Fri, 07 Feb 2025SEK 44.1bSEK 17.0b-SEK 1,038,511,426.0044x-42.4x2.6x
Sun, 05 Jan 2025SEK 43.5bSEK 16.7b-SEK 1,152,911,426.0049.2x-37.8x2.6x
Tue, 03 Dec 2024SEK 42.4bSEK 16.7b-SEK 1,154,323,426.0049x-36.7x2.5x
Thu, 31 Oct 2024SEK 43.8bSEK 16.8b-SEK 956,465,491.0051.1x-45.8x2.6x
Sat, 28 Sep 2024SEK 48.3bSEK 16.7b-SEK 988,175,491.0059.2x-48.9x2.9x
Mon, 26 Aug 2024SEK 48.7bSEK 16.7b-SEK 986,068,538.0061.2x-49.4x2.9x
Wed, 24 Jul 2024SEK 49.2bSEK 16.6b-SEK 1,138,220,510.0059.8x-43.3x3x
Fri, 21 Jun 2024SEK 42.6bSEK 16.3b-SEK 1,188,686,510.0055x-35.9x2.6x
Sun, 19 May 2024SEK 42.2bSEK 16.3b-SEK 1,188,457,671.0060.7x-35.5x2.6x
Tue, 16 Apr 2024SEK 38.3bSEK 16.0b-SEK 1,122,792,213.0035.3x-34.1x2.4x
Thu, 14 Mar 2024SEK 40.4bSEK 16.0b-SEK 1,123,139,210.0042x-35.9x2.5x
Sat, 10 Feb 2024SEK 39.7bSEK 15.8b-SEK 1,473,823,683.0056.5x-26.9x2.5x
Mon, 08 Jan 2024SEK 35.9bSEK 15.5b-SEK 1,393,723,683.0043.5x-25.8x2.3x
Wed, 06 Dec 2023SEK 35.2bSEK 15.5b-SEK 1,393,723,683.0042.2x-25.3x2.3x
Fri, 03 Nov 2023SEK 31.0bSEK 15.4b-SEK 1,255,923,711.0034.1x-24.7x2x
Sun, 01 Oct 2023SEK 26.8bSEK 15.1b-SEK 1,134,516,711.0039.8x-23.6x1.8x
Tue, 29 Aug 2023SEK 30.6bSEK 15.1b-SEK 1,138,067,831.0041x-26.9x2x
Thu, 27 Jul 2023SEK 33.0bSEK 14.9b-SEK 239,671,038.0047.5x-137.6x2.2x
Sat, 24 Jun 2023SEK 35.7bSEK 14.6b-SEK 172,476,038.0038.7x-207.1x2.4x
Mon, 22 May 2023SEK 39.6bSEK 14.6b-SEK 175,477,906.0040.1x-225.6x2.7x
Wed, 19 Apr 2023SEK 32.5bSEK 14.6b-SEK 57,449,459.0034.1x-566x2.2x
Fri, 17 Mar 2023SEK 34.1bSEK 14.6b-SEK 57,185,459.0031.9x-596.2x2.3x
Sun, 12 Feb 2023SEK 40.4bSEK 14.4bSEK 827.0m37.3x48.9x2.8x
Tue, 10 Jan 2023SEK 39.7bSEK 14.2bSEK 943.9m40.5x42.1x2.8x
Thu, 08 Dec 2022SEK 37.1bSEK 14.1bSEK 944.3m41.9x39.3x2.6x
Sat, 05 Nov 2022SEK 33.6bSEK 13.9bSEK 761.4m48.6x44.1x2.4x
Mon, 03 Oct 2022SEK 32.9bSEK 13.5bSEK 750.9m48.3x43.8x2.4x
Price to Earnings Ratio

43.8x


Total Market Cap: SEK 32.9bTotal Earnings: SEK 750.9mTotal Revenue: SEK 13.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average -30.3x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 566x which is higher than its 3-year average PE of -30.3x.
  • The industry is trading close to its 3-year average PS ratio of 2.5x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 57% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market-1.57%
Healthcare-3.35%
Life Sciences-5.87%
Clinical Research and Equipment-5.87%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News

MCAP
SEK 553.00
MedCap
7D
-9.3%
1Y
9.7%

Is MedCap (STO:MCAP) Using Too Much Debt?

Sep 25
Is MedCap (STO:MCAP) Using Too Much Debt?
BICO
SEK 20.64
BICO Group
7D
-4.3%
1Y
-51.9%
ALIF B
SEK 179.30
AddLife
7D
-4.5%
1Y
13.2%

Optimized Product Portfolio And Acquisitions Will Deliver Future Value

Despite a slight decrease in consensus revenue growth forecasts, AddLife’s fair value estimate was marginally raised, with the analyst price target increasing from SEK196.50 to SEK200.00. Valuation Changes Summary of Valuation Changes for AddLife The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from SEK196.50 to SEK200.00.
GENO
SEK 23.00
Genovis AB (publ.)
7D
-8.4%
1Y
-17.6%
IDLDX
SEK 0.40
IDL Diagnostics
7D
-3.4%
1Y
-22.5%
PRO
SEK 16.60
Promimic
7D
-0.9%
1Y
-54.0%
MAGLE
SEK 18.70
Magle Chemoswed Holding
7D
-6.5%
1Y
-51.6%

Investors Give Magle Chemoswed Holding AB (publ) (STO:MAGLE) Shares A 26% Hiding

Aug 12
Investors Give Magle Chemoswed Holding AB (publ) (STO:MAGLE) Shares A 26% Hiding
LEVBIO
SEK 0.32
Level Bio
7D
-1.8%
1Y
-24.7%